Allied Corp.
ALID
$0.145
-$0.0296-16.95%
| Weiss Ratings | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.26 | |||
| Price History | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 7.73% | |||
| 30-Day Total Return | 223.20% | |||
| 60-Day Total Return | 134.20% | |||
| 90-Day Total Return | 106.91% | |||
| Year to Date Total Return | 100.75% | |||
| 1-Year Total Return | -5.22% | |||
| 2-Year Total Return | -82.24% | |||
| 3-Year Total Return | -83.51% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -44.93% | |||
| 52-Week Low % Change | 727.73% | |||
| Price | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.32 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Mar 01, 2024 | |||
| 52-Week High Price (Date) | May 24, 2023 | |||
| Valuation | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 17.35M | |||
| Enterprise Value | 23.50M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.10 | |||
| Earnings Per Share Growth | 33.58% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 820.00 | |||
| Price/Book (Q) | -2.31 | |||
| Enterprise Value/Revenue (TTM) | 1,145.39 | |||
| Price | $0.16 | |||
| Enterprise Value/EBITDA (TTM) | -2.83 | |||
| Enterprise Value/EBIT | -2.79 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 105.79M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877-255-4337 | |||
| Address | 460 Doyle ave Kelowna, BC V1YOC2 | |||
| Website | allied.health | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -41,003.72% | |||
| Profit Margin | -41,880.93% | |||
| Management Effectiveness | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -131.19% | |||
| Return on Equity | -- | |||
| Income Statement | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 21.50K | |||
| Total Revenue (TTM) | 21.50K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -1.49M | |||
| EBITDA (TTM) | -8.71M | |||
| EBIT (TTM) | -8.82M | |||
| Net Income (TTM) | -9.00M | |||
| Net Income Avl. to Common (TTM) | -9.00M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 58.06% | |||
| EPS Diluted (TTM) | -0.09 | |||
| EPS Diluted Growth (Q YOY) | 61.50% | |||
| Balance Sheet | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 101.60K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 767.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -7.53M | |||
| Current Ratio (Q) | 0.079 | |||
| Book Value Per Share (Q) | -$0.07 | |||
| Total Assets (Q) | 2.29M | |||
| Total Current Liabilities (Q) | 9.72M | |||
| Total Debt (Q) | 6.25M | |||
| Total Liabilities (Q) | 9.82M | |||
| Total Common Equity (Q) | -7.53M | |||
| Cash Flow | ALID - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -11.50K | |||
| Cash from Financing (TTM) | 1.82M | |||
| Net Change in Cash (TTM) | -63.20K | |||
| Levered Free Cash Flow (TTM) | -3.65M | |||
| Cash from Operations (TTM) | -1.18M | |||
